Published in Medical Device Business Week, February 11th, 2009
Separately, Alexion announced that it is currently initiating clinical trials of eculizumab in patients with aHUS. Soliris is approved in the United States,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.